Drug Shortage Report for PRIVA-CIPROFLOXACIN
Report ID | 100886 |
Drug Identification Number | 02445344 |
Brand name | PRIVA-CIPROFLOXACIN |
Common or Proper name | CIPROFLOXACIN |
Company Name | PHARMAPAR INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-12-09 |
Estimated end date | 2020-08-28 |
Actual end date | 2020-08-17 |
Shortage status | Resolved |
Updated date | 2020-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-08-18 | English | Compare |
v8 | 2020-08-17 | French | Compare |
v7 | 2020-08-17 | English | Compare |
v6 | 2020-07-28 | French | Compare |
v5 | 2020-07-28 | English | Compare |
v4 | 2020-03-04 | French | Compare |
v3 | 2020-03-04 | English | Compare |
v2 | 2019-12-10 | French | Compare |
v1 | 2019-12-10 | English | Compare |
Showing 1 to 9 of 9